The global non-alcoholic steatohepatitis market, or NASH drugs market, is valued at USD 7.48 billion in 2024 and is poised to reach at USD 71.69 billion by 2035, representing a CAGR value of 22.8% during the forecast period. The Global Non-alcoholic Steatohepatitis Market Report is a comprehensive report on the Non-alcoholic Steatohepatitis market, offering key insights on business strategies,...